Cargando…
Optimal long peptide for flagellin-adjuvanted HPV E7 cancer vaccine to enhance tumor suppression in combination with anti-PD-1
BACKGROUND: Therapeutic cancer vaccines, which induce or amplify tumor-specific T cell responses, are a critical component of multiple combination cancer immunotherapy regimens. Innovative neoantigen identification continually prompts the development of vaccine platforms. However, vaccine monotherap...
Autores principales: | Lee, Hye Hwa, Hong, Seol Hee, Rhee, Joon Haeng, Lee, Shee Eun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273650/ https://www.ncbi.nlm.nih.gov/pubmed/35836530 http://dx.doi.org/10.21037/tcr-21-2798 |
Ejemplares similares
-
Combination of Photodynamic Therapy and a Flagellin-Adjuvanted Cancer Vaccine Potentiated the Anti-PD-1-Mediated Melanoma Suppression
por: Hwang, Hye Suk, et al.
Publicado: (2020) -
Intranasal immunization with a flagellin-adjuvanted peptide anticancer vaccine prevents tumor development by enhancing specific cytotoxic T lymphocyte response in a mouse model
por: Nguyen, Chung Truong, et al.
Publicado: (2013) -
Deimmunization of flagellin for repeated administration as a vaccine adjuvant
por: Khim, Koemchhoy, et al.
Publicado: (2021) -
Flagellin is a strong vaginal adjuvant of a therapeutic vaccine for genital cancer
por: Lee, Shee Eun, et al.
Publicado: (2015) -
Mucosal immunization with a flagellin-adjuvanted Hgp44 vaccine enhances protective immune responses in a murine Porphyromonas gingivalis infection model
por: Puth, Sao, et al.
Publicado: (2017)